DNA damage repair biomarkers, p-DNA-PK and Rad51, were reduced by knockdown of PDIA6, suggesting that PDIA6 promoted DNA damage repair to enhance the resistance of renal cell carcinoma to imatinib. Here, PRKDC is linked to renal cell carcinoma.